news

Infrared light used to improve photodynamic therapy in model tumours

Researchers have developed a compound that can be activated with infrared light to kill cancer cells in model tumours, advancing the possibilities of photodynamic therapy.

Red laser light

Scientists have discovered a new light-sensitive compound which they suggest could improve photodynamic therapy (PDT) for cancer. 

The study was conducted at the University of Sheffield, UK. The team report that their sensitiser molecule uses penetrating infrared light to damage cells directly and potentially improve the success rate of PDT. 

When administered to the patients and activated by light, PDT molecules produce highly reactive oxygen-based species which kill cancer cells. However, current treatments have two main drawbacks:

 

Reserve your FREE place

 


Reduce preclinical failures with smarter off-target profiling

24 September 2025 | 15:00PM BST | FREE Webinar

Join this webinar to hear from Dr Emilie Desfosses as she shares insights into how in vitro and in silico methods can support more informed, human-relevant safety decisions -especially as ethical and regulatory changes continue to reshape preclinical research.

What you’ll learn:

  • Approaches for prioritizing follow-up studies and refining risk mitigation strategies
  • How to interpret hit profiles from binding and functional assays
  • Strategies for identifying organ systems at risk based on target activity modulation
  • How to use visualization tools to assess safety margins and compare compound profiles

Register Now – It’s Free!

 

  • sensitisers are only activated by light energies that do not penetrate tissues like skin very deeply
  • many tumours have low amounts of oxygen, so photoactivated sensitisers cannot generate the toxic compounds which kill cancer cells.

However, the novel compound solves both of these problems in one go. Not only is it activated by infrared or red light which can penetrate deep into the tumour, but it also directly damages DNA within cells without having to rely on oxygen.

The researchers have tested the compound on skin cancer models and observed that it kills cancer cells deep into these tumours. According to the team, the next step in their studies will investigate skin models, testing whether the compound can kill the tumour but leave healthy skin undamaged.

Lead researcher Professor Jim Thomas, from the University of Sheffield’s Department of Chemistry, said: “PDT is potentially a very attractive way to treat diseases such as skin cancer as it only works when the laser light is applied, so the effect can be focused into a specific place on or in the body. The sensitiser we have developed can potentially solve the two main problems that prevent PDT from being a commonly used anticancer treatment.”

The research was published in the Journal of the American Chemical Society.

Leave a Reply

Your email address will not be published. Required fields are marked *